Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms

Human Pathology

Volumn 42, Issue 10, 2011, Pages 1373-1384

  La Rosa, Stefano ^a   Inzani, Frediano ^b   Vanoli, Alessandro ^c   Klersy, Catherine ^d   Dainese, Linda ^e   Rindi, Guido ^b   Capella, Carlo ^a,e   Bordi, Cesare ^f   Solcia, Enrico ^c,d  

^a OSPEDALE DI CIRCOLO   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e UNIVERSITY OF INSUBRIA   (Italy)

^f UNIVERSITY OF PARMA   (Italy)

Author keywords

Carcinoid; Grading; Neuroendocrine neoplasm; Prognosis; Stomach

Indexed keywords

GASTRIN; SEROTONIN; SOMATOSTATIN;

ARTICLE; CANCER CELL; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CARCINOMA; DISEASE SEVERITY; ENDOCRINE TUMOR; ENTEROCHROMAFFIN CELL; EXOCRINE CARCINOMA; FEMALE; GASTRIN CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; OVERALL SURVIVAL; PROGNOSIS; SEROTONIN CELL; SOMATOSTATIN CELL; STOMACH CARCINOMA; TUMOR GROWTH;

CARCINOMA, NEUROENDOCRINE; HUMANS; NEOPLASM STAGING; NEOPLASMS, COMPLEX AND MIXED; NEUROENDOCRINE TUMORS; PROGNOSIS; STOMACH NEOPLASMS;

EID: 80053195715     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.01.018     Document Type: Article

References (34)

1. Rindi G., Azzoni C., and La Rosa S. ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis Gastroenterology 116 1999 532 542 (Pubitemid 29106760)
2. Modlin I.M., Kidd M., Latich I., Zikusoka M.N., and Shapiro M.D. Current status of gastrointestinal carcinoids Gastroenterology 128 2005 1717 1751 (Pubitemid 40692562)
3. E. Solcia Histological typing of endocrine tumours. WHO International Histological Classification of Tumours 2nd ed. 2000 Springer Berlin, Germany
4. Capella C., Solcia E., Sobin L.H., and Arnold R. Endocrine tumours of the stomach S.R. Hamilton, World Health Organization Classification of Tumours. Pathology & genetics of tumours of the digestive system 2000 IARC Press Lyon, France 53 57
5. Rindi G., Arnold R., and Bosman F.T. Nomenclature and classification of neuroendocrine neoplasms of the digestive system F.T. Bosman, WHO classification of tumours of the digestive system 2010 IARC Press Lyon, France 13 14
6. Rindi G., Klöppel G., and Alhman H. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system Virchows Arch 449 2006 393 401
7. Klöppel G., Couvelard A., Perren A. Mallorca Consensus Conference participants, and European Neuroendocrine Tumor Society ENETS consensus guidelines for the standards of care in neuroendocrine tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification Neuroendocrinology 90 2009 162 166
8. Klimstra D.S., Modlin I.R., and Adsay N.V. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set Am J Surg Pathol 34 2010 300 313
9. Solcia E., Arnold R., and Capella C. Neuroendocrine neoplasms of the stomach F.T. Bosman, WHO classification of tumours of the digestive system 2010 IARC Press Lyon, France 64 68
10. Solcia E., Capella C., Vassallo G., and Buffa R. Endocrine cells of the gastric mucosa Int Rev Cytol 42 1975 223 286
11. Rindi G., Necchi V., and Savio A. Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and fetal tissues Histochem Cell Biol 117 2002 511 519 (Pubitemid 34666954)
12. Carney J.A., Go V.L., Fairbanks V.F., Moore S.B., Alport E.C., and Nora F.E. The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy Ann Intern Med 99 1983 761 766 (Pubitemid 14248401)
13. Solcia E., Capella C., Fiocca R., Rindi G., and Rosai J. Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association Am J Surg Pathol 14 1990 503 513 (Pubitemid 20172521)
14. Rindi G., Luinetti O., Cornaggia M., Capella C., and Solcia E. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study Gastroenterology 104 1993 994 1006 (Pubitemid 23090750)
15. Matsui K., Kitagawa M., Miwa A., Kuroda Y., and Tsuji M. Small cell carcinoma of the stomach: a clinicopathologic study of 17 cases Am J Gastroenterol 86 1991 1167 1175
16. Jiang S.X., Mikami T., Umezawa A., Saegusa M., Kameya T., and Okayasu I. Gastric large cell neuroendocrine carcinomas: a distinct clinicopathologic entity Am J Surg Pathol 30 2006 945 953 (Pubitemid 44264942)
17. Shia J., Tang L.H., and Weiser M.R. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity? Am J Surg Pathol 32 2008 719 731 (Pubitemid 351600819)
18. Chiaravalli A.M., Klersy C., and Tava F. Lower- and higher-grade subtypes of diffuse gastric cancer Hum Pathol 40 2009 1591 1599
19. Borch K., Ahrén B., Ahlman H., Falkmer S., Granérus G., and Grimelius L. Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type Ann Surg 242 2005 64 73 (Pubitemid 40917969)
20. Ruszniewski P., Delle Fave G., and Cadiot G. Well-differentiated gastric tumors/carcinomas Neuroendocrinology 84 2006 158 164 (Pubitemid 46361049)
21. Campana D., Nori F., and Pezzilli R. Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs Endocr Relat Cancer 15 2008 337 342 (Pubitemid 351449751)
22. Schmitt A.M., Anlauf M., and Rousson V. WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors Am J Surg Pathol 31 2007 1677 1682 (Pubitemid 350287565)
23. Pape U.F., Jann H., and Muller-Nordhorn J. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors Cancer 113 2008 256 265
24. La Rosa S., Klersy C., and Uccella S. Improved histologic and clinico-pathologic criteria for prognostic evaluation of pancreatic endocrine tumors Hum Pathol 40 2009 30 40
25. Ekeblad S., Skogseid B., Dunder K., Oberg K., and Eriksson B. Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution Clin Cancer Res 14 2008 7798 7803
26. Scarpa A., Mantovani W., and Capelli P. Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients Mod Pathol 2010 824 833
27. Soga J., and Tazawa K. Pathologic analysis of carcinoids. Histologic revaluation of 62 cases Cancer 28 1971 990 998
28. Volante M., Brizzi M.P., and Faggiano A. Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy Mod Pathol 20 2007 1172 1182 (Pubitemid 47609066)
29. Abraham S.C., Carney J.A., Ooi A., Choti M.A., and Argani P. Achlorhydria, parietal cell hyperplasia, and multiple gastric carcinoids. A new disorder Am J Surg Pathol 29 2005 969 975 (Pubitemid 40885022)
30. Hosokawa O., Kaizaki Y., and Hattori M. Long-term follow up of patients with multiple gastric carcinoids associated with type A gastritis Gastric Cancer 8 2005 42 46 (Pubitemid 40394925)
31. Kumashiro R., Naitoh H., Teshima K., Sakai T., and Inutsuka S. Minute gastric carcinoid tumor with regional lymph node metastasis Int Surg 74 1989 198 200 (Pubitemid 19247543)
32. Xie S.D., Wang L.B., Song X.Y., and Pan T. Minute gastric carcinoid tumor with regional lymph node metastasis: a case report and review of literature World J Gastroenterol 10 2004 2461 2463 (Pubitemid 39157785)
33. Soga J. Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases Cancer 103 2005 1587 1595 (Pubitemid 40490019)
34. Furlan D., Cerutti R., and Genasetti A. Microallelotyping defines the monoclonal or the polyclonal origin of mixed and collision endocrine-exocrine tumors of the gut Lab Invest 83 2003 963 971 (Pubitemid 36899063)